MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2025-06-30, SGMT had -$33,513K decrease in cash & cash equivalents over the period.

Cash Flow Overview

Change in Cash
-$33,513K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-06-30
Net (decrease) increase in cash and cash equivalents
-33,513
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Sagimet Biosciences Inc. (SGMT)

Sagimet Biosciences Inc. (SGMT)